...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Term sheet and enterprise valuation

What we need is an answer to where are we going,what is plan and liquidity.I have placed that question with IR for the AGM.

Share
New Message
Please login to post a reply